Endocrine · 2026
Risk factors of renal complications in childhood-onset non-surgical hypoparathyroidism: a long-term follow-up study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chen Yingying, Gao Yiyang, Wang Jiajia, Song An, Jiang Yan, Li Mei, Xia Weibo, Xing Xiaoping, Wang Ou
Аннотация
CONTEXT: It is unclear about the prevalence and risk factors of renal complications in childhood-onset patients with non-surgical hypoparathyroidism (ns-HP), which significantly hinders the clinical management and prognosis improvement. OBJECTIVE: To investigate the prevalence and risk factors of chronic renal complications in childhood-onset ns-HP patients receiving conventional therapy. DESIGN AND SETTING: A retrospective cohort in childhood-onset patients with ns-HP at a tertiary care center, between 1977 and 2022. PATIENTS AND METHODS: Childhood-onset ns-HP patients who received conventional treatment and were followed for at least 1 year were enrolled. Kaplan-Meier survival analysis and Cox regression were performed to identify the risk factors of renal complications. Time-dependent ROC curves were utilized to explore their optimal cutoff values. RESULTS: A total of 143 patients were enrolled in our cohort. Excluding 6 cases with pre-existed RC, 29/137 (21.17%) cases developed renal calcification (RC) during follow-up of 11.5 ± 8.5 years. Compared with patients without RC, they had a higher proportion of hypercalciuria (52.69 ± 32.8% vs. 35.64 ± 25.84%, P = 0.015) and renal insufficiency (RI) (17.24% vs. 3.70%, P = 0.021). Serum calcium-phosphate product (Ca×PO4) (HR = 1.205, P = 0.033) and hypercalciuria proportion (HR = 1.048, P = 0.043) were independent risk factors for RC, with optimal cutoffs of 41.96 mg²/dL² (AUC = 0.735) and 60% (AUC = 0.697), respectively. RI occurred in 6.29% (9/143) of patients, and the highest serum TCa during treatment (HR = 7.277, P = 0.019) was the risk factor of RI. CONCLUSION: To reduce RC risk in childhood-onset ns-HP patients on conventional treatment, it is essential to consistently control the serum Ca×PO₄ and urinary calcium excretion. Hypercalcemia during the treatment should be avoided to prevent RI.